Company / SG&A per Share
Silo Pharma, Inc. SG&A per Share History
FY2019-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.07
FY2023
5-year range
$0.00 / $0.07
FY2019-FY2023
Trend
+1851.7%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share changed +1852% YoY in FY2023, a notable deviation from the 2-year average annual change of +933%.
Based on SEC 10-K filings.
0.07 in FY2023.
Increased from $0.00 to $0.07 over the past 4 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +169.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, sg&a per share increased 1851.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.07 | +1851.7% |
| FY2020 | $0.00 | +13.5% |
| FY2019 | $0.00 | - |
As of FY2023 · SEC 10-K · Updated Jun 28, 2026